Halozyme Therapeutics Inc
(NAS:HALO)
$
102.62
+0.020 (+0.02%)
Market Cap: 11.65 Bil
Enterprise Value: 13.56 Bil
PE Ratio: 30.63
PB Ratio: 86.67
GF Score: 81/100 Halozyme Therapeutics Inc (HALO) Transcripts
- 1